Work

Effects of SRX246, a Vasopressin 1a Receptor (V1a) Antagonist, on an Experimental Model of Phasic and Sustained Threat in Humans

Year: 2020

Type: article

Source: Biological Psychiatry

DOI: 10.1016/j.biopsych.2020.02.443

Authors: Tiffany Lago, Michael Brownstein, Emily Beydler, Adrienne Manbeck, Alexis Beale, Neal Simon, Monique Ernst, Christian Grillon

Institutions: Azevan Pharmaceuticals (United States), National Institute of Mental Health

Language: English

Topic: Neuroendocrine regulation and behavior

Subfield: Social Psychology

Field: Psychology

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3022852891

FWCI: 0.273

Cites:

Cited by: 3

Related to: 10